ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,599.30
0.49%
Dow Jones
41,350.93
-0.20%
US Dollar vs MXN
20.1768
-0.01%
Brent Oil
70.60
-0.13%
Bitcoin
83,623.79
-0.07%
Pepperstone
Advertisement
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Tevogen Bio Holdings Inc (TVGN)

  7. Tevogen Bio Holdings Inc (TVGN) Noticias

TVGN

Tevogen Bio (TVGN)

Tevogen Bio Holdings Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:TVGN
FechaHoraFuenteTítuloSímboloCompañía
10/03/202511:40GlobeNewswire Inc.Tevogen Bio Announces Unique T Cell Vaccine Under Development and Files Patent with the USPTONASDAQ:TVGNTevogen Bio Holdings Inc
07/03/202515:09GlobeNewswire Inc.Tevogen Bio’s CIO & Head of Tevogen.AI, Mittul Mehta, Featured Speaker at Proskauer’s AI Discussion PanelNASDAQ:TVGNTevogen Bio Holdings Inc
03/03/202511:52GlobeNewswire Inc.Tevogen Bio to Receive $8 Million of Non-Dilutive Grant Funding, Reiterates Efficient OperationsNASDAQ:TVGNTevogen Bio Holdings Inc
28/02/202512:17GlobeNewswire Inc.Tevogen Bio Founder and CEO Dr. Ryan Saadi Named to 2025 NJBIZ Power 100, Celebrating Innovation and Leadership in Accessible T Cell TherapyNASDAQ:TVGNTevogen Bio Holdings Inc
21/02/202514:28GlobeNewswire Inc.Tevogen Bio’s First Trading Year Efficiency: 600% Higher Market Cap Per Team Member, 79% Insider-OwnedNASDAQ:TVGNTevogen Bio Holdings Inc
14/02/202517:31GlobeNewswire Inc.Tevogen Bio CEO Reinforces Commitment to Retention of Equity Capital and Long-Term VisionNASDAQ:TVGNTevogen Bio Holdings Inc
14/02/202512:16GlobeNewswire Inc.Tevogen Bio Shares 2024 Financing Activity on One Year Anniversary of Becoming a Publicly Listed Company; Highlights Operational EfficiencyNASDAQ:TVGNTevogen Bio Holdings Inc
14/02/202510:52GlobeNewswire Inc.Tevogen Bio CEO Addresses Short Selling and Its Potential Impact on the Nation’s Health and ProsperityNASDAQ:TVGNTevogen Bio Holdings Inc
13/02/202515:34GlobeNewswire Inc.Tevogen Bio CEO Congratulates RFK Jr. on His Confirmation as Secretary of the HHS; Echoes Commitment to Innovation and Affordability for AmericansNASDAQ:TVGNTevogen Bio Holdings Inc
10/02/202516:30GlobeNewswire Inc.Tevogen Bio's Business Model Addresses Biopharma Industry Challenges with Cost-Efficient InnovationNASDAQ:TVGNTevogen Bio Holdings Inc
07/02/202513:56GlobeNewswire Inc.Tevogen Bio Meets BARDA TechWatch Team, Highlighting ExacTcell™ Technology’s Potential as a Scalable Medical CountermeasureNASDAQ:TVGNTevogen Bio Holdings Inc
28/01/202514:49GlobeNewswire Inc.Tevogen Bio Enters Agreement to Receive Up To $10 Million of Non-Dilutive Grant FundingNASDAQ:TVGNTevogen Bio Holdings Inc
27/01/202513:24GlobeNewswire Inc.Tevogen Bio CEO Congratulates Lynne Patton on Being Appointed Deputy Assistant to the President and Director of Minority OutreachNASDAQ:TVGNTevogen Bio Holdings Inc
24/01/202516:34GlobeNewswire Inc.Tevogen Bio Broadens Relationship with Microsoft to Deepen Artificial Intelligence Collaboration and Develop PredicTcell Technology on AzureNASDAQ:TVGNTevogen Bio Holdings Inc
23/01/202518:53GlobeNewswire Inc.Tevogen Bio Highlights the Future of AI-Driven Drug Development in Fireside Chat with Microsoft During the J.P. Morgan Healthcare ConferenceNASDAQ:TVGNTevogen Bio Holdings Inc
26/12/202411:21GlobeNewswire Inc.Tevogen Bio to Host Panel Discussions “AI In Biopharma: Next Frontier of Medical Innovation” and “Pioneering the Economics of Health: Balancing Access and Outcomes” During J.P. Morgan Healthcare ConferenceNASDAQ:TVGNTevogen Bio Holdings Inc
23/12/202408:38GlobeNewswire Inc.Tevogen Bio to Host Panel "AI In Biopharma: Next Frontier of Medical Innovation" During the 43rd Annual J.P. Morgan Healthcare ConferenceNASDAQ:TVGNTevogen Bio Holdings Inc
19/12/202407:30GlobeNewswire Inc.Tevogen Bio Strengthens Robust IP Portfolio With Filing of Predictive AI Patent, With the Goal to Establish a Blueprint to Unlock the Full Potential of T Cell Therapies and Accelerate AI Integration to Advance Its Bold Growth AgendaNASDAQ:TVGNTevogen Bio Holdings Inc
17/12/202412:32GlobeNewswire Inc.Tevogen Bio to Host Panel “Pioneering the Economics of Health: Balancing Access and Outcomes” During the 43rd Annual J.P. Morgan Healthcare ConferenceNASDAQ:TVGNTevogen Bio Holdings Inc
10/12/202414:13GlobeNewswire Inc.Tevogen Bio to Attend the 43rd Annual J.P. Morgan Healthcare ConferenceNASDAQ:TVGNTevogen Bio Holdings Inc
05/12/202410:03GlobeNewswire Inc.Dr. Ryan Saadi Commends Individuals Who Dedicate Time to Public Service, and Congratulates Mayor Victor Sordillo on His Induction Into the NJ League of Municipalities Hall of FameNASDAQ:TVGNTevogen Bio Holdings Inc
26/11/202407:05GlobeNewswire Inc.Tevogen Bio Prepares Organizational Readiness to Support Company’s Growth StrategyNASDAQ:TVGNTevogen Bio Holdings Inc
21/11/202414:59GlobeNewswire Inc.Tevogen Bio CEO Reflects on Public Support, Reaffirms Preserving Shareholder Value Remains His Priority, and Reinforces Options Including a Potential Share Buyback to Support Company ValueNASDAQ:TVGNTevogen Bio Holdings Inc
19/11/202415:50GlobeNewswire Inc.Tevogen Bio Reports Third Quarter 2024 Financial Results; Highlights Significantly Improved Financial Position, Unreported Asset Value on Balance Sheets, Efficient Business ModelNASDAQ:TVGNTevogen Bio Holdings Inc
14/11/202416:00GlobeNewswire Inc.UPDATE - Tevogen Founder Reflects on Importance of Preserving Shareholder Value While Navigating Growth as it Prepares to File Quarterly FinancialsNASDAQ:TVGNTevogen Bio Holdings Inc
14/11/202414:49GlobeNewswire Inc.Tevogen Founder Reflects on Importance of Preserving Shareholder Value While Navigating Growth as it Prepares to File Quarterly FinancialsNASDAQ:TVGNTevogen Bio Holdings Inc
08/11/202414:36GlobeNewswire Inc.Tevogen Bio Nears Finalization of Agreement to Enhance R&D and Manufacturing Capabilities; $36 Million Line of Credit Available for Continued OperationsNASDAQ:TVGNTevogen Bio Holdings Inc
05/11/202415:43GlobeNewswire Inc.Tevogen Bio CEO Dr. Ryan Saadi Expresses Gratitude for Prestigious ROI-NJ Recognition, Highlighting Company’s Novel Business Model as Key to Sustainable Success through Patient AffordabilityNASDAQ:TVGNTevogen Bio Holdings Inc
05/11/202408:27GlobeNewswire Inc.Tevogen Bio Leverages Microsoft Partnership to Deliver Machine Learning Based Target Identification to Address Human Papilloma Virus (HPV), Advancing TVGN 920NASDAQ:TVGNTevogen Bio Holdings Inc
04/11/202413:36GlobeNewswire Inc.Tevogen Bio Announces Appointment of Anthony Tarantino as Patient Advocate to Enhance Community Engagement and Patient SupportNASDAQ:TVGNTevogen Bio Holdings Inc
 Showing the most relevant articles for your search:NASDAQ:TVGN

Su Consulta Reciente

TG
FPO
Petra Diamonds
ASX
SGI
Stealth
ASX
BM8
Battery Age Minerals
ASX
TCG
Turaco Gold
TG
LGQM
Amundi Pan Africa UCITS ...
LSE
ACR
Abbeycrest
TG
VHM
Sacyr
BIT
CRB
Amundi Bloomberg Equal-w...
LSE
AAZ
Anglo Asian Mining
NEO
JPM
JPMorgan CDR CAD Hedged
NYSE
RH
RH
ASX
EMD
Emyria
TG
IFGA
Atari
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2025 ADVFN PLC - Todos los derechos reservados

Quitar anuncios

Suscríbete a una experiencia sin publicidad

Sin anuncios

Pruébalo ahora

Mantenga los anuncios